chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dull headache, bad body aches, very tired, my periods became very very heavy.; Dull headache, bad body aches, very tired, my periods became very very heavy.; Dull headache, bad body aches, very tired, my periods became very very heavy.; Dull headache, bad body aches, very tired, my periods became very very heavy.; This is a spontaneous report from a contactable consumer. This 46-Year-Old female consumer reported for herself, a 46-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot Number: EL3247), dose 2 via an unspecified route of administration, administered in Arm Left on 18Mar2021 11:30 (age at the time of vaccination was 46-year-old) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medications included colecalciferol (VITAMIN D [COLECALCIFEROL]); vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]); biotin (BIOTIN); ubidecarenone (COQ-10); cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]) (all concomitant medications) was taken for an unspecified indication, start and stop date was not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot Number: EL3247), dose 1 via an unspecified route of administration, administered in Arm Left on 25Feb2021 02:00 as dose 1, single for COVID-19 immunization. The patient did not receive any other vaccine prior to COVID-19 Vaccine. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. It was reported by the patient that she experienced dull headache, bad body aches, very tired, my periods became very very heavy on 19Mar2021 01:00. No treatment was received for all the events. Outcome of all the events was reported as recovering. No follow-up attempts are possible. No further information is expected.
no adverse affects reported; patients received doses of improperly stored Varivax; This spontaneous report was received from a health professional and refers to a patient of unknown gender and age. The patient's concurrent conditions, medical history, concomitant therapies, drug reaction and allergies were not reported.   On an unknown date in April 2019 (reported as 25-APR-2019 or 26-APR-2019), the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) subcutaneously, lot # R034396, expiration date 27-NOV-2020, (dose was not reported) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 38 degrees Fahrenheit for 72 hours. Sterile diluent was stored properly. There were no previous excursions reported. Data logger was not involved. No adverse effects was reported.  This is on of eleven reports from the same reporter.; Sender's Comments:  US-009507513-1904USA013210: US-009507513-1904USA013265: US-009507513-1904USA013269: US-009507513-1904USA013270: US-009507513-1904USA013272: US-009507513-1904USA013275: US-009507513-1904USA013276: US-009507513-1904USA013278: US-009507513-1904USA000187: US-009507513-1904USA000191:
After 6pm my joints especially my knees started to ache.  My normal temperature is 97.5.  I had a low grade fever of  99.2 by 8:45pm, and felt cold for the next twelve hours. Right arm very sore, took a Naproxen Sodium 220mg at 8:15pm.  Temperature dropped to 98.5 by 11pm. Still felt achy, chilled, and fatigued, in bed and asleep by 11:35pm.  Slept till 9am the next day.  Ate a light breakfast, and took 325 mg Acetaminophen.  After lunch another Acetaminophen, and a nap from 3-5pm.  Aches and chills persisted till bed time the next night.  Broke a sweat in the early morning on the 18th.  Felt okay the rest of the day and after.
pt recv vax & next 12hr cried inconsolably for 10hr;beyond 12hr pt has been fine
Shingles in the abdomen appeared 7 days after injection to the 58 yr. old male.
Pt. reports arm soreness, discomfort and weakness. Symptoms started day of injection and are still bothersome as of 6/20/14 (8 mon). Pain from shoulder to about 5 inches below in triceps region.
The adverse event reported occurred five and half months after COVID vaccination and involved a swollen and painful throat with inflamed uvula. Given the long duration between vaccination and this event, I do not believe there was any relation between the throat inflammation I experienced and the COVID vaccination. Three Self-administered COVID tests were all negative. Urgent care prescribed Decadron steroidal anti-inflammatory, which was taken on-site.
Small red area about the size of a quarter with blisters on left thigh. Still has scabs and is still tender.
11/1/08, given flu shot high on left arm into joint, sore to begin with; and as of 12/1 developed into unmovable joint, unable to lift arm and disrupts sleep.
I started getting a large rash at the top of my left thigh. It was raised, itchy, and blotchy. I thought I was having an allergic reaction. It stayed for 1 week. Then 10-14 days later, my left leg swelled up very large suddenly. I was scared and worried. I called my doctor and they told me to go to the ER. I went to the ER and was admitted to the hospital. I was given Heparin. I was diagnosed with a DVT blood clot. It was very large. I stayed one night in the hospital for observation. I also had blood work, ultrasound, and CT scan. It just now is starting to decrease in size and swelling. I am now taking Eliquis. Next week I have an appointment with a hematologist. I never had oral thrush but now this is the second time after the 3rd dose that I have had it. I went to the ER as well and I was told that now I am getting colonized by bacteria. I was given Nystatin oral for thrush.
SOME LOSE  BOWELS; SEVERE CHILLS; FEVER/HOT; SWEATS; This spontaneous report received from a patient concerned a 70 year old of unspecified sex. The patient's height, and weight were not reported. The patient's concurrent conditions included immune thrombocytopenic purpura, and multiple neurological issues, and other pre-existing medical conditions included .The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 22-JUN-2021 13:15 for prophylactic vaccination. Concomitant medications included ivermectin. On 22-JUN-2021, the subject experienced sweats. On 22-JUN-2021, the subject experienced severe chills. On 22-JUN-2021, the subject experienced fever/hot. On 23-JUN-2021, the subject experienced some lose bowels. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever/hot, severe chills, and sweats, and the outcome of some lose bowels was not reported. This report was non-serious.
Patient reported that at the site of injection she had a red bullseye, warm, hard nodule. She said it start the day after the injection and it was now day 5 since injection and still had symptoms. She did apply ice. She did visit local walk in clinic on 1/9/2016. She told me the doctor looked at it and said she is fine just reaction at site from vaccine.
After vaccine, extreme blood pressure fluctuations, trouble with dizziness, lightheaded, feeling like fainted (fainted once), trouble catching breath, significant weight gain because unable to exercise/move as normally. Referred to cardiologist because migraines and chest pain.
pt recv vax 20MAY97 & devel varicella lesions 2OCT97 lasting 102wk but mild case (less than 75 pox, not very ill);17OCt had acute onset of ataxia;had negative head MRI in ER but reacted w/prolonged sedation;
Patient states her right arm has had a tingling effect since after getting her flu shot. She has gotten the flu vaccine in the past without any issues. She states it's tingling at bedtime when she's sleeping and occasionally throughout the day.
had blood test / results showed elevation / C-reactive protein (CRP) levels; blood test / showed elevation with Sedimentation Rate; This case was reported by a physician and described the occurrence of c-reactive protein increased in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, several days after receiving Shingrix, the patient experienced c-reactive protein increased and elevated sedimentation rate. On an unknown date, the outcome of the c-reactive protein increased and elevated sedimentation rate were unknown.   It was unknown if the reporter considered the c-reactive protein increased and elevated sedimentation rate to be related to Shingrix.  Additional details were provided as follows: Age at vaccination was not reported. The patient received Shingrix, a few days after had blood test done and results showed elevation with Sedimentation Rate and C-reactive protein (CRP) levels. The physician stated did not know if dose was first or second of Shingrix, since they didn't administer vaccine. The physician unable to provide any vaccine details. The reporter did not consent to follow-up.
patient accidentally received a moderna(spikevax) vaccine. called pharmacy and wanted to talk to manager. I was not in work until 11/2/23 and called patient that day and patient stated that she had a swollen/inflammation to arm last week, but now it is just bruised.
Follow up information received from a health care provider on 11 September 2007.  A 16-year-old female patient with a medical history of depression and attention deficit disorder, had received a left arm injection of Menactra (route not reported), lot number U2233C, and a right arm injection of Gardasil (route not reported), lot number U2233CA (lot number reported is consistent with Menactra) on 30 July 2007, and five days later, she complained of a headache and stomach ache.  A strep test was performed (date not provided) and the results were negative.  The patient had been taking Zoloft and Concerta at the time of vaccination.  Corrective treatment for the event consisted of Tylenol and ibuprofen.  The patient was not ill at the time of vaccination and they had not received any vaccines during the four weeks prior to receipt of Menactra.  The duration for the event was not indicated and the patient had been listed as recovered at the time of the report.  No further information was provided.
Injection site slight swelling and redness, became more swollen and a larger area over several days. Also very itchy.
Severe vomiting for 8 hours and some diarrhea. Head fuzziness comes and goes along with nausea. Started  May 21st, still have some nausea, slight diarrhea and fuzziness on May 26.
Onset numbness/ weakness in legs, ascending over 24 hours to involve pelvis and arms to lesser degree. Hospitalized. Neuro consult.
Patient reports feeling faint/dizzy.  VSS BP 118/69, HR82 -- > 103/63, 63.  Observed for 15mins, patient stable and released from vaccination site.
pt recvd vax & mom stated leg & foot are swollen x 1 1/2 days (lt leg & foot); advised to take to MD for swelling; mom states pt had no temp; 17JAN95 mom states was area on lt toe w/pus;
Information has been received from a physician concerning a 17 year old female patient who on 05-OCT-2007 and 29-NOV-2007 was vaccinated with the first and second doses of GARDASIL, respectively. It was reported that post vaccination the patient complained of severe bruising on her arm and leg, without impact. It is unknown exactly where on the arm or leg bruising occurred. The patient was hospitalized and "lots of tests were performed" leading to a diagnosis of immune thrombocytopenia. The patient was treated with "Immunoglobulin Intravenous," and was discharged from the hospital. At the time of this report the patient's outcome was unknown. No product quality complaint was involved. Immune thrombocytopenia was considered to be an other medically important event. Additional information has been requested.
Pt. states 04/22/2021 @10:30am after receiving 2nd dose she started experiencing awful heart pounding and digestive issues. Heart palpations, disturbed sleep reported with fatigue.
extreme body aches; chills; 101 F. fever; can't get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (extreme body aches), CHILLS (chills), PYREXIA (101 F. fever) and FATIGUE (can't get out of bed) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient had a severe case of COVID-19 in December that led to pneumonia) in December 2020 and Pneumonia (Patient had a severe case of COVID-19 in December that led to pneumonia) in December 2020.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (extreme body aches), CHILLS (chills), PYREXIA (101 F. fever) and FATIGUE (can't get out of bed). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 18-Feb-2021, PAIN (extreme body aches), CHILLS (chills), PYREXIA (101 F. fever) and FATIGUE (can't get out of bed) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: high 101 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
IM  given in left arm 3rd dose. (Booster). Moderna Covid-19 Vaccine Lot 045C21A given was removed from freezer on 10/6/21 at 11:45 am. Given on 11/5/21, out of time range. Patient contacted that evening. Moderan manufacturer called. Patients called the following Monday letting them know that Moderna was looking into this and would be getting back to us. Also let them know I would be following up with them once we heard back from them. Called patient today 11/17/21 and let him know that Moderan let us know the  vaccine was viable, no additional booster vaccine is required.
received his first Shingrix dose a little over 2 years ago; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 76-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Zostavax (Zostavax 5 years ago) and Shingrix (received his first dose a little over 2 years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: received his first Shingrix dose a little over 2 years ago). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 06-JUN-2023 The reporter was the patient.  The patient could not afford the second dose of Shingrix 6 months later.  He planned to receive the second dose at the time of reporting (Inappropriate schedule of vaccine). Nothing else was reported. The reporter did not consent to follow-up. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
it felt like i had a ministroke or a hemiplegic migraine. partial blurred vision in one eye, right side of face was numb, pressure in the back of head, mouth tasted like metal, and some lip tingling hours after the initial incident.
L upper arm with 2x4 cm area of redness and mild induration well circumscribed, mildly tender and warm vaccine imm reaction. No cellulitis. 7/29/06 seen again for persisting 5 x 6cm erythema and fever DX with cellulitis places on Keflex.
who was also fully vaccinated - also tested positive for Covid; who was also fully vaccinated - also tested positive for Covid; This is a spontaneous report from a contactable Physician. A female patient of an unspecified age received first dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot numbers were not reported) via an unspecified route of administration on an unspecified dates as dose 1, single and received second dose of bnt162b2 (COMIRNATY, Formulation: Solution for injection, Batch/Lot numbers were not reported) via an unspecified route of administration on an unspecified dates as dose 2, single for covid-19 immunisation. The medical history and concomitant medications were not reported. The reporter stated patient who was also fully vaccinated - also tested positive for covid on an unspecified date. The outcome of the event patient who was also fully vaccinated - also tested positive for covid was unknown. The patient underwent lab test and procedures on an unknown date which included SARS-VoV-2 test: Positive tested positive for Covid with symptoms lasting for more than a week. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events and the suspected vaccine BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
Received VARIVAX and seasonal flu vaccine - (L) arm - 1/28/10 - (L) arm started itching that night - spreading to trunk and legs. Nausea.
Headache from 8p the night of until 12n the day after the shot. Treated unsuccessfully with tylenol and advil. Resolved itself. Chills and fever alternating from 8p the night of until 5a the morning after the shot. Resolved itself.  Body aches from 11p the night of until 5a the morning after the shot. Resolved itself.
INJECTION SITE SWOLLEN, HOT, looked like a bull's eye, neck/shoulder/clavicle swollen, tender with hardened lymph node.
Felt syncope - dizzy/lightheaded. Unconscious progressing awoke - coworker caught her the second time - similar event last yr. after flu vaccine.
No further adverse effect; patient received a dose of improperly stored VAQTA; This spontaneous report was received from a medical assistant and refers to a patient of unknown age. The patient's pertinent medical history, drug reactions, allergies and concomitant therapies were not provided.  On 20-FEB-2020, the patient was vaccinated with one improperly stored dose of hepatitis A vaccine, inactivated (VAQTA) (lot# S025993, expiration date 17-OCT-2020) (exact dose, frequency and route of administration were not reported) for prophylaxis. The administered vaccine were stored in a temperature below 36 Fahrenheit degrees (F) (34F) for 27 minutes. No previous temperature excursions were reported. Digital data logger was involved. No adverse effects were reported.
1st dose of Shingrix in 2018; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report.  The reporter wanted to get 2nd dose of Shingrix. The patient did not receive 2nd dose till the time of reporting which led to incomplete course of vaccination. The health care professional provided limited information regarding patient's demographic details and vaccines lot number and expiration date since the patient received 1st dose of Shingrix at another facility.  The reporter consented to follow up.
10 mins after injection, patient complaint of blotchy redness/itching at injection site, brought back to obs, rash improved as patient sat in obs, vss, no worsening of s/s. escorted to private vehicle without issues
Fever, chills, and body aches began 04/29/2020, after the injection.  Awoke on 05/04/09 to swelling and aches all over, and pain with walking.  The following day, 05/05/19 treated in a local Emergency Room.  Blood work, CTscan, chest x-ray, and nasal swab reportedly completed.  Antibiotic given and sent home.  Reports that the ER stated she had elevated transaminases.  Employee then missed work on Monday, 05/06/2019 due to the illness.  I was made aware of the issue on 05/09/2019.  On 05/10/2019 the employee still reported achy joints and lower extremity swelling, but both were reportedly improved from the prior weekend.  She was still on the antibiotics.  The employee had spoken to her primary care physician and scheduled a follow-up for June 2019.  On 05/22/2019, reported feeling better everyday. On June 12, 2019 the employee reported her liver enzymes were back to normal after evaluation with her primary care physician.
Had uncontrollable violent shaking for about an hour, then fever and chills all night and the next day with vomiting. Missed 2 days of work.
Patient was give 0.25ml (not the full 0.5ml that she was supposed to receive).  I got the recommended info from Moderna to complete the vaccine.
Pfizer-BioNTech COVID-19 Vaccine EUA No diluent, resulting in higher than authorized dose
Large red induration. Tender warm to touch at site. Low grade temp 99.3 (tympanic).
arm became is extremely red covering an area of half a palm of a hand; very itchy; itchiness started, but came and went; left arm was a little achy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness started, but came and went), INJECTION SITE ERYTHEMA (arm became is extremely red covering an area of half a palm of a hand), INJECTION SITE PRURITUS (very itchy) and VACCINATION SITE PAIN (left arm was a little achy) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: pneumococcal shot. Concomitant products included VITAMIN D NOS, MECOBALAMIN (VITAMIN B12 [MECOBALAMIN]) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE PAIN (left arm was a little achy). On 17-Mar-2021, the patient experienced PRURITUS (itchiness started, but came and went). On 23-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (arm became is extremely red covering an area of half a palm of a hand) and INJECTION SITE PRURITUS (very itchy). On 17-Mar-2021, VACCINATION SITE PAIN (left arm was a little achy) outcome was unknown. At the time of the report, PRURITUS (itchiness started, but came and went), INJECTION SITE ERYTHEMA (arm became is extremely red covering an area of half a palm of a hand) and INJECTION SITE PRURITUS (very itchy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, White blood cell count: 2,8 (Low) 2,8.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was reported.